|[September 01, 2014]
Elekta: Enhanced collaboration with Toshiba strengthens Elekta's position in Japan
TOKYO --(Business Wire)--
In an agreement signed today in Tokyo, Elekta Japan will grant Toshiba (News - Alert)
Medical Systems Corporation (TMSC) wider distribution rights regarding
linear accelerator (linac) sales. The agreement builds on a sales and
marketing agreement from 2010 (http://www.elekta.com/press/44337b95-6e69-4e41-926d-aaa6d6dbf002/elekta-signs-sales-and-marketing-agreement-with-toshiba-in-japan-.html).
Shuichi Higaki, President and Managing Director, Elekta Japan, says:
"The existing partnership between Elekta and TMSC from 2010 has helped
raise Elekta's profile in the Japanese market. This new agreement
creates significant opportunities for Elekta to further increase our
customer satisfaction and become the leading supplier of oncology
systems and related software solutions in Japan."
The agreement also includes the intention to develop the Elekta Support
Center, a centralized customer support center with a single point of
contact for all Elekta linac users in Japan. Elekta will continue to
manage marketing and promotion of all Elekta products and solutions, as
well as education and training and software service support.
# # #
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial
Instruments Trading Act. The information was published at 07:30 CET on
September 1, 2014.
Elekta is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The company
develops sophisticated, state-of-the-art tools and treatment planning
systems for radiation therapy, radiosurgery and brachytherapy, as well
as workflow enhancing software systems across the spectrum of cancer
care. Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer confidence to
both health care providers and patients, Elekta aims to improve, prolong
and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over
6,000 hospitals worldwide. Elekta employs around 3,800 employees
globally. The corporate headquarters is located in Stockholm, Sweden,
and the company is listed on the Nordic Exchange under the ticker
STO:EKTAB. Website: www.elekta.com.
This information was brought to you by Cision http://news.cision.com
[ Back To TMCnet.com's Homepage ]